BNP Paribas Asset Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.1K Buy
4,143
+1,123
+37% +$14K ﹤0.01% 1762
2025
Q4
$35K Buy
3,020
+793
+36% +$9.31K ﹤0.01% 1781
2025
Q3
$28K Buy
2,227
+82
+4% +$1.19K ﹤0.01% 1269
2025
Q2
$34K Buy
+2,145
New +$32.1K ﹤0.01% 1293
2023
Q4
Sell
-9,285
Closed -$317K 866
2023
Q3
$317K Buy
9,285
+728
+9% +$27.7K ﹤0.01% 808
2023
Q2
$342K Sell
8,557
-532,261
-98% -$21.2M ﹤0.01% 804
2023
Q1
$21.2M Buy
540,818
+2,009
+0.4% +$73.7K 0.07% 278
2022
Q4
$17.2M Buy
538,809
+186,285
+53% +$5.62M 0.06% 333
2022
Q3
$9.99M Buy
352,524
+7,145
+2% +$244K 0.04% 408
2022
Q2
$12.3M Sell
345,379
-9,829
-3% -$397K 0.05% 375
2022
Q1
$17.5M Buy
355,208
+46,213
+15% +$2.44M 0.06% 320
2021
Q4
$17.2M Buy
308,995
+203,346
+192% +$11.2M 0.06% 349
2021
Q3
$6.13M Buy
105,649
+363
+0.3% +$22.4K 0.02% 505
2021
Q2
$6.66M Sell
105,286
-9,882
-9% -$651K 0.02% 500
2021
Q1
$7.35M Buy
115,168
+690
+0.6% +$40K 0.03% 460
2020
Q4
$5.99M Buy
114,478
+14,180
+14% +$699K 0.03% 466
2020
Q3
$4.39M Buy
100,298
+13,127
+15% +$580K 0.02% 468
2020
Q2
$3.84M Buy
87,171
+14,180
+19% +$600K 0.03% 480
2020
Q1
$2.83M Buy
72,991
+7,200
+11% +$367K 0.02% 499
2019
Q4
$3.72M Buy
65,791
+8,915
+16% +$497K 0.03% 518
2019
Q3
$3.03M Buy
56,876
+39,858
+234% +$2.14M 0.02% 539
2019
Q2
$993K Buy
17,018
+1,703
+11% +$91.5K 0.01% 662
2019
Q1
$759K Sell
15,315
-1,553
-9% -$68.4K 0.01% 741
2018
Q4
$626K Buy
16,868
+5,395
+47% +$196K 0.01% 769
2018
Q3
$433K Hold
11,473
﹤0.01% 810
2018
Q2
$502K Hold
11,473
﹤0.01% 827
2018
Q1
$577K Buy
11,473
+842
+8% +$49.6K ﹤0.01% 806
2017
Q4
$700K Sell
10,631
-1,279
-11% -$81.3K 0.01% 780
2017
Q3
$712K Sell
11,910
-10,827
-48% -$644K 0.01% 782
2017
Q2
$1.47M Buy
22,737
+1,974
+10% +$125K 0.01% 698
2017
Q1
$1.3M Sell
20,763
-6,314
-23% -$380K 0.01% 728
2016
Q4
$1.56M Sell
27,077
-8,685
-24% -$513K 0.02% 692
2016
Q3
$2.13M Buy
35,762
+847
+2% +$52K 0.02% 706
2016
Q2
$2.17M Sell
34,915
-2,528
-7% -$156K 0.02% 676
2016
Q1
$2.31M Buy
37,443
+5,210
+16% +$307K 0.02% 650
2015
Q4
$1.96M Sell
32,233
-4,641
-13% -$276K 0.02% 673
2015
Q3
$1.86M Sell
36,874
-146,597
-80% -$7.81M 0.02% 690
2015
Q2
$9.46M Buy
183,471
+59,559
+48% +$3.08M 0.08% 345
2015
Q1
$6.31M Buy
123,912
+113,734
+1,117% +$5.87M 0.05% 423
2014
Q4
$542K Buy
10,178
+1,399
+16% +$71.2K ﹤0.01% 834
2014
Q3
$400K Buy
8,779
+1,473
+20% +$69.3K ﹤0.01% 842
2014
Q2
$346K Hold
7,306
﹤0.01% 875
2014
Q1
$336K Buy
+7,306
New +$338K ﹤0.01% 859

Other funds holding XRAY

BNP Paribas Asset Management's XRAY Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Dentsply Sirona (XRAY) stake by 37% in Q1 2026, buying an estimated $14K and bringing the position to 4,143 shares worth $48.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1762.

BNP Paribas Asset Management first reported a position in XRAY in Q1 2014 and has held it in 43 quarters since. The position peaked at $21.2M in Q1 2023. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • BNP Paribas Asset Management held 4,143 shares of Dentsply Sirona worth $48.1K as of Q1 2026.
  • BNP Paribas Asset Management bought 1,123 Dentsply Sirona shares in Q1 2026, an estimated $14K.
  • Dentsply Sirona made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #1762 holding.
  • BNP Paribas Asset Management first reported a position in Dentsply Sirona in Q1 2014 and has held it in 43 quarters since.
  • BNP Paribas Asset Management's Dentsply Sirona position peaked at $21.2M in Q1 2023.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.